M
Michael Robinson
Researcher at Queen's University
Publications - 7
Citations - 2865
Michael Robinson is an academic researcher from Queen's University. The author has contributed to research in topics: Colorectal cancer & Randomized controlled trial. The author has an hindex of 5, co-authored 7 publications receiving 2795 citations. Previous affiliations of Michael Robinson include University of Nottingham.
Papers
More filters
Journal ArticleDOI
Randomised controlled trial of faecal-occult-blood screening for colorectal cancer
Jack D. Hardcastle,Jocelyn Chamberlain,Michael Robinson,Sue Moss,Satya S Amar,Tom Balfour,Peter D. James,Christine M Mangham +7 more
TL;DR: Evidence from this study and other trials suggest that consideration should be given to a national programme of FOB screening to reduce CRC mortality in the general population.
Journal ArticleDOI
Recognition and labeling of delirium symptoms by intensivists: does it matter?
Catherine Z. Cheung,Shabbir M.H. Alibhai,Michael Robinson,George Tomlinson,Dean R. Chittock,John W. Drover,Yoanna Skrobik +6 more
TL;DR: Canadian intensivists diagnose delirium based upon the presence or absence of an obvious medical etiology, and wide variation exists in approach to management, as well as patterns of consultation.
Journal ArticleDOI
Change towards earlier stage at presentation of colorectal cancer.
TL;DR: An increase in the proportion of patients with symptomatic early‐stage rectosigmoid cancer has been observed in the past 10 years and no such change occurred in those with colonic cancer.
Journal ArticleDOI
HOMOGRAFT REPLACEMENT OF THE AORTIC VALVE: Immediate Results and Follow-up
TL;DR: Of the 109 patients discharged from hospital with aortic homograft valves the result is considered excellent in 35, good in 38, satisfactory in 11, and poor in 10.
Journal ArticleDOI
Fecal α1-antitrypsin detection of colorectal neoplasia : an evaluation using HemoQuant
Alex Moran,Alex Moran,Michael Robinson,Michael Robinson,Nigel Lawson,Nigel Lawson,Julie Stanley,Julie Stanley,Alan F. Jones,Alan F. Jones,Jack D. Hardcastle,Jack D. Hardcastle +11 more
TL;DR: Fecal α 1-antitrypsin measurement may be of value for the detection of coloreactal neoplasia and is compared with the HemoQuant test in 119 subjects with either a screen-positive Hemoccult result (N=78) or iron-deficiency anaemia (N =41) as mentioned in this paper.